E
Day One Biopharmaceuticals, Inc. DAWN
$9.73 $0.748.23% NASDAQ
Recommendation
Prev Close
$8.99
Volume
5,792,876
Avg Vol (90D)
1,623,495
Market Cap
$923.05M
Dividend & Yield
--
52-Week Range
$5.64 - $16.76
P/E (TTM)
--
EPS (TTM)
-$1.48
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
11/7/2025 - Ticker Report
Notable Friday Option Activity: DAWN, PYPL, ANGI
11/7/2025 - Stock Options Channel
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 8.5% - Time to Buy?
11/7/2025 - Ticker Report
Equities Analysts Offer Predictions for DAWN FY2029 Earnings
11/7/2025 - MarketBeat
Day One Biopharmaceuticals price target raised by $1 at JPMorgan, here's why
11/7/2025 - The Fly
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
11/7/2025 - Simply Wall St
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Raised to $26.00
11/6/2025 - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Better-Than-Expected Earnings
11/6/2025 - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Issues Earnings Results
11/6/2025 - Ticker Report
Day One Biopharmaceuticals (DAWN, $9.14) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 5, 2025
11/6/2025 - Tickeron - Stocks
Day One Biopharmaceuticals (DAWN, $9.14) entered Uptrend as Momentum indicator ascends above 0 level on Nov 05, 2025
11/6/2025 - Tickeron - Stocks
Day One Biopharmaceuticals (DAWN, $9.14) RSI Indicator left the overbought zone on November 05, 2025
11/6/2025 - Tickeron - Stocks
Day One Biopharmaceuticals (DAWN): Fastest Projected Revenue Growth Challenges Undervaluation Narrative Ahead of Earnings
11/5/2025 - Simply Wall St
Day One Biopharmaceuticals (NASDAQ:DAWN) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS
11/5/2025 - MarketBeat
Day One Biopharmaceuticals price target raised by $1 at Piper Sandler, here's why
11/5/2025 - The Fly
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...
11/5/2025 - GuruFocus
Q3 2025 Day One Biopharmaceuticals Inc Earnings Call Transcript
11/5/2025 - GuruFocus
Day One Biopharmaceuticals (DAWN) Reports Strong Q3 2025 Earnings
11/5/2025 - GuruFocus
Day One Biopharmaceuticals, Inc. (DAWN) Q3 2025 Earnings Call Transcript
11/5/2025 - Seeking Alpha: Transcripts
Day One Biopharmaceuticals, Inc. (DAWN) Q3 2025 Earnings Call Transcript
11/5/2025 - SeekingAlpha
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates
11/4/2025 - Zacks Investment Research
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings: EPS of -$0. ...
11/4/2025 - GuruFocus
Day One Biopharmaceuticals reports Q3 EPS (19c), consensus (28c)
11/4/2025 - The Fly
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
11/4/2025 - Globe Newswire
Day One Biopharmaceuticals (DAWN, $7.31) Stochastic Oscillator left the oversold zone on November 03, 2025
11/4/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$133.67M
EBITDA (TTM)
-$162.41M
EBIT (TTM)
-$165.62M
Net Income (TTM)
-$151.76M
Balance Sheet
Total Assets (Q)
$513.78M
Total Debt (Q)
$2.89M
Total Liabilities (Q)
$62.91M
Book Value Per Share (Q)
$4.39
Cash Flow
Cash from Operations (TTM)
-$119.62M
Cash from Investing (TTM)
-$262.47M
Cash from Financing (TTM)
$2.60M
Net Change in Cash (TTM)
-$379.49M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.50
7-Day Total Return
38.21%
30-Day Total Return
43.72%
60-Day Total Return
55.68%
90-Day Total Return
44.58%
Year to Date Total Return
-23.45%
1-Year Total Return
-38.26%
2-Year Total Return
-21.28%
3-Year Total Return
-50.05%
5-Year Total Return
--
52-week Low
Aug 06, 2025 - $5.64
52-week High
Nov 08, 2024 - $16.76
Valuation
Market Cap
$923.05M - Small Cap
Enterprise Value
$474.37M
Price/Sales (TTM)
6.95
Price/Book (Q)
2.05
Dividends and Shares
Shares Outstanding
103.38
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
dayonebio.com
Phone Number
650 484 0899
Address
1800 Sierra Point Parkway
Brisbane, CA 94005
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company’s lead... more
NASDAQ 11/07/2025 4:00PM Eastern Quotes delayed